Flurbiprofeno [Inn-Spanish] en es it fr

Flurbiprofeno [Inn-Spanish] Brand names, Flurbiprofeno [Inn-Spanish] Analogs

Flurbiprofeno [Inn-Spanish] Brand Names Mixture

  • No information avaliable

Flurbiprofeno [Inn-Spanish] Chemical_Formula


Flurbiprofeno [Inn-Spanish] RX_link


Flurbiprofeno [Inn-Spanish] fda sheet

Flurbiprofeno_[Inn-Spanish] FDA

Flurbiprofeno [Inn-Spanish] msds (material safety sheet)

Flurbiprofeno_[Inn-Spanish] MSDS

Flurbiprofeno [Inn-Spanish] Synthesis Reference

No information avaliable

Flurbiprofeno [Inn-Spanish] Molecular Weight

244.261 g/mol

Flurbiprofeno [Inn-Spanish] Melting Point

110-111 oC

Flurbiprofeno [Inn-Spanish] H2O Solubility

8 mg/L

Flurbiprofeno [Inn-Spanish] State


Flurbiprofeno [Inn-Spanish] LogP


Flurbiprofeno [Inn-Spanish] Dosage Forms

Capsule (sustained-release); Liquid; Tablet

Flurbiprofeno [Inn-Spanish] Indication

Flurbiprofen tablets are indicated for the acute or long-term treatment of the signs and symptoms of rheumatoid arthritis and osteorarthritis.

Flurbiprofeno [Inn-Spanish] Pharmacology

Flurbiprofen, a nonsteroidal antiinflammatory drug (NSAID) of the propionic acid class, is used for the relief of pain and inflammation associated with rheumatoid arthritis and osteoarthritis and for the inhibition of intraoperative miosis. Flurbiprofen exhibits antiinflammatory, analgesic, and antipyretic activities.

Flurbiprofeno [Inn-Spanish] Absorption

The mean oral bioavailability of flurbiprofen from tablets is 96% relative to an oral solution.

Flurbiprofeno [Inn-Spanish] side effects and Toxicity

LD50=10 mg/kg (orally in dogs).

Flurbiprofeno [Inn-Spanish] Patient Information

Flurbiprofeno [Inn-Spanish] Organisms Affected

Humans and other mammals